Technology: COVID
Industry: AI, End-to-end Drug Development
Headquarters: Daejeon, Taejon-jikhalsi, South Korea
Founded Date: 2016-12-06
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 6
Total Funding: 19647275
Last Funding Date: 2022-02-24
Last Funding Type: Series B

Visit Website
contact@deargen.me
Register and Claim Ownership